MIND Foundation
Join us for profound explorations into the human mind. Established in 2016, MIND has become the leading platform for interdisciplinary debate and training in the field of psychedelics and culture of consciousness. We go where others don't, and we doubt where others believe. Join us on a fascinating journey of bridging science and experience.
MIND is a European non-profit science and education organization - promoting evidence-based, safe, and legal applications of the psychedelic experience. Our YouTube channel organizes public talks, workshops, trainings, member's debates, and webinars. We host Europe's most innovative conference on the science of psychedelic therapies and practices: the INSIGHT: https://insight-conference.eu.
More: https://mind-foundation.org
Our partner - OVID Clinic Berlin - is Europe's first day clinic for psychiatry and psychotherapy that adds psychedelic strategies to its guideline-based medical interventions: https://ovid-clinics.com
Forum Bewusstseinskultur: From Illusions to Solutions - How Could Psychedelics Make a Contribution?
Regulating Psychedelic Therapy as a Medicine - the Evolving Australian Experience
Psychedelische Therapie & Forschung: Interview mit Lea Mertens (ZI Mannheim)
Psychedelics, Leadership, and Systems Change
Psychedelic Prescribing in Australia: Local Challenges and Opportunities, Global Lessons
How Can We Change the World? Vision of the German Federal Agency for Disruptive Innovation (SPRIND)
Symposium: The Varieties of Indigenous Practices - Diversity of Psychedelic Use
Psychedelic Neuroexistentialism
Psychedelic Experience and the Releasement of Death Anxiety
Panel: Investing in Therapies or Molecules? Patients vs Patents
Immersive Therapeutic Frameworks in Psychedelic-Based Treatments
How Can Psychedelics Create a More Integrated and Patient-Centric Approach to Mental Health?
Can Psychedelics Provide Insights into Consciousness?
Using Your Breath to Change Your Mind: New Insights Into How Breathwork Alters Physiology
Using EEG to Measure Human Neuroplasticity in Psychedelic Research
Subjective Time and Body-Self During Altered States of Consciousness: New Evidence
Serotonin Modulation of Drug-Evoked Synaptic Plasticity in Cocaine Addiction
Mapping the Neuro-Behavioral Space of Self-Dissolution and Self-Other Differentiation
Increased Plasticity in Hippocampus and Prefrontal Cortex Following Psychedelic Administration
Group VR Experiences Can Produce Ego Attenuation and Connectedness Comparable to Psychedelics
From Concept to Funding & Development: A Negev Labs Psychedelic Drug Discovery Platform
Allosteric BDNF-TrkB Signalling as the Target for Psychedelic and Antidepressant Drugs
What’s Love Got to Do With It? Emotional Connection, Personal Boundaries, Compassion Fatigue in PAT
What Do You Want To Know: An Opportunity To Discuss Naive and Not So Naive Questions
How Psilocin and a Serotonin Blocker Affect Brain Responses to Sound in Rats
Symposium: Psychedelics and Spiritualities - A Journey to Therapy and Beyond (3)
Symposium: Psychedelics and Spiritualities - A Journey to Therapy and Beyond (1)
Symposium: Psychedelics and Spiritualities - A Journey to Therapy and Beyond (2)
Symposium: Psychedelics and Spiritualities - A Journey to Therapy and Beyond (4)
After the Therapy: From Treatment to Growth - A Conversation with Patients